Adrenomed was featured in the Deutsche Welle report “On the wave of BioNTech success – is it becoming easier to get financing for innovation?” Check out the video with Andreas Bergmann, CSO, and Frauke Hein, CBO, on the mode of action of Adrecizumab and the economic potential of biotech in Germany.